ClinicalTrials.Veeva

Menu

Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship (WBPBM-PSC)

U

Universidade Federal de Sao Carlos

Status

Enrolling

Conditions

Sports
Muscle Strength
Muscle Fatigue
Athletic Performance

Treatments

Radiation: Sham PBM
Radiation: Whole-Body Photobiomodulation (PBM) (Active PBM)

Study type

Interventional

Funder types

Other

Identifiers

NCT07224646
84660524.7.0000.5504

Details and patient eligibility

About

This study aims to investigate the effects of whole-body photobiomodulation on professional soccer players during a state championship. The primary question is whether photobiomodulation improves recovery, reduces muscle fatigue, and enhances performance compared to standard training without photobiomodulation.

Full description

Detailed Description:

This randomized, controlled clinical trial aims to evaluate the effects of whole-body photobiomodulation (PBM) on recovery and performance in professional soccer players during a state championship.

The intervention will be performed twice weekly on non-consecutive days for 8 weeks, in combination with each athlete's standard training routine. Participants will be allocated to either an active PBM group or a sham PBM group, both following identical procedures to maintain blinding.

Throughout the study, participants will complete scheduled assessments at baseline, during, and after the 8-week period to monitor performance, muscle soreness, and hematological responses. Data will be analyzed using appropriate statistical tests, with a significance level of 5% (two-tailed).

Enrollment

24 estimated patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male professional soccer players currently competing in the championship
  • Age 18-35 years
  • Training frequency ≥5 times per week
  • Able to attend all PBM/sham sessions and all assessments during the 8-week intervention
  • Signed informed consent

Exclusion criteria

  • Lower-limb musculoskeletal injury in the last 6 months or currently receiving treatment
  • Current use of phototherapy or any other recovery-enhancing modality
  • Chronic medical conditions that may affect performance or recovery
  • Known sensitivity or contraindication to light-based therapies
  • Inability to comply with the intervention or training schedule

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

24 participants in 2 patient groups, including a placebo group

Active PBM
Experimental group
Description:
Whole-body PBM delivered with a Joovv Elite System (6 LED panels; 660±10 nm red and 850±10 nm near-infrared; total panel area ≈12,193 cm²). Athlete stands \~20 cm from panels, wearing eye protection. Two exposures per session: 450 s anterior + 450 s posterior (total 15 min). Measured average irradiance ≈81.62 mW/cm² and energy density per region ≈25.71 J/cm² at 20 cm. Two sessions/week on non-consecutive days for 8 weeks, after routine training.
Treatment:
Radiation: Whole-Body Photobiomodulation (PBM) (Active PBM)
Sham PBM
Placebo Comparator group
Description:
Identical setup and schedule, but with therapeutic light disabled (placebo light only). Eye protection and blinding procedures identical to active PBM.
Treatment:
Radiation: Sham PBM

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Italo A Oliveira, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems